Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kimiara Heram is a leading Iranian pharmaceutical company specializing in the marketing, distribution, and supply of high-quality medicinal products and medical devices. Established in 2006 as part of the Kimiara Group, the company focuses on therapeutic areas such as oncology, hematology, nephrology, and urology. They maintain strategic partnerships with international pharmaceutical firms, including CSL Vifor and Astellas, to bring innovative treatments to the Iranian market. Kimiara Heram is particularly recognized for its portfolio in iron deficiency management and specialized hospital products. The company provides comprehensive services including regulatory affairs, market access, and scientific marketing to ensure patient access to advanced therapies. Their operations are centered in Tehran, serving a wide network of hospitals and pharmacies across the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kimiara Heram.